Inspire Medical Systems (NYSE: INSP) insider transactions
In the twelve months to 10 November 2026, executives and directors of Inspire Medical Systems reported 7 open-market sales of 8,309 shares ($665,952) and 0 open-market purchases, by 3 people, according to the Form 4 filings they submitted to the SEC.
Latest transactions
| Date | Insider | Role | Transaction | Shares | Price | Held after | Filing |
|---|---|---|---|---|---|---|---|
| 14 October 2026 | Broader Shelley G | Director | Grant or award | +284 | $68.07 | 9,138 | Form 4 |
| 14 October 2026 | Carrel Michael H | Director | Grant or award | +203 | $68.07 | 5,834 | Form 4 |
| 14 October 2026 | Melenikiotou Georgia | Director | Grant or award | +255 | $68.07 | 8,584 | Form 4 |
| 14 October 2026 | Ellis Gary Lee | Director | Grant or award | +431 | $68.07 | 11,850 | Form 4 |
| 31 August 2026 | Kelly Jason P | See Remarks | Grant or award | +6,350 | — | 25,335 | Form 4 |
| 7 August 2026 | Kelly Jason P | See Remarks | Open-market sale | −963 | $59.55 | 18,985 | Form 4 |
| 31 July 2026 | Mann Melissa | Chief People Officer | Shares withheld for tax | −326 | $50.21 | 22,957 | Form 4 |
| 20 July 2026 | Carrel Michael H | Director | Grant or award | +5,631 | — | 5,631 | Form 4 |
| 15 July 2026 | Broader Shelley G | Director | Grant or award | +383 | — | 8,854 | Form 4 |
| 15 July 2026 | Ellis Gary Lee | Director | Grant or award | +581 | — | 11,419 | Form 4 |
| 15 July 2026 | Tansey Casey M | Director | Grant or award | +346 | — | 26,632 | Form 4 |
| 15 July 2026 | Melenikiotou Georgia | Director | Grant or award | +344 | — | 8,329 | Form 4 |
| 15 May 2026 | Rondoni John | See Remarks | Open-market sale | −2,641 | $43.28 | 27,165 | Form 4 |
| 14 May 2026 | Rondoni John | See Remarks | Open-market sale | −700 | $43.01 | 29,806 | Form 4 |
| 8 May 2026 | mcCormick Shawn | Director | Open-market sale, 10b5-1 plan | −696 | $45.31 | 27,712 | Form 4 |
| 1 May 2026 | Melenikiotou Georgia | Director | Shares withheld for tax | −50 | $56.70 | 7,985 | Form 4 |
| 30 April 2026 | Melenikiotou Georgia | Director | Grant or award | +3,562 | — | 8,035 | Form 4 |
| 30 April 2026 | mcCormick Shawn | Director | Grant or award, 10b5-1 plan | +3,562 | — | 28,408 | Form 4 |
| 30 April 2026 | Broader Shelley G | Director | Grant or award | +3,562 | — | 8,471 | Form 4 |
| 30 April 2026 | Burks Cynthia | Director | Grant or award | +3,562 | — | 6,213 | Form 4 |
Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.
How to read the table
Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.
Where each row comes from
From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Inspire Medical Systems page; the method, in data sources.
Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.